Cardizem and Sinusitis chronic - a phase IV clinical study of FDA data

Summary:

Sinusitis chronic is found among people who take Cardizem, especially for people who are female, 40-49 old.

The phase IV clinical study analyzes which people take Cardizem and have Sinusitis chronic. It is created by eHealthMe based on reports of 26,718 people who have side effects when taking Cardizem from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

26,718 people reported to have side effects when taking Cardizem.
Among them, 47 people (0.18%) have Sinusitis chronic.

What is Cardizem?

Cardizem has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 27,643 Cardizem users for its effectiveness, alternative drugs and more.

What is Sinusitis chronic?

Sinusitis chronic (long lasting infection of sinus) is found to be associated with 1,380 drugs and 485 conditions by eHealthMe.

Number of Cardizem and Sinusitis chronic reports submitted per year:

Gender of people who have Sinusitis chronic when taking Cardizem *:

female: 86.05 %
male: 13.95 %

Age of people who have Sinusitis chronic when taking Cardizem *:

Common drugs people take besides Cardizem *:

Common side effects people have besides Sinusitis chronic *:

Stress And Anxiety: 39 people, 82.98%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 37 people, 78.72%
Back Pain: 36 people, 76.60%
Pain: 36 people, 76.60%
Osteopenia (a condition where bone mineral density is lower than normal): 34 people, 72.34%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 33 people, 70.21%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 33 people, 70.21%
Osteonecrosis Of Jaw (death of bone of jaw): 33 people, 70.21%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 33 people, 70.21%
Rashes (redness): 31 people, 65.96%

Common conditions people have *:

Metastatic Neoplasm (spreadable cancer tumour): 20 people, 42.55%
Breast Cancer Metastatic: 19 people, 40.43%
Hypersensitivity: 13 people, 27.66%
Stress And Anxiety: 13 people, 27.66%
Diabetes: 12 people, 25.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 4.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.26%
Enlarged Prostate: 1 person, 2.13%
Blood Cholesterol Decreased: 1 person, 2.13%
Constipation: 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem and have Sinusitis chronic?

Check whether Sinusitis chronic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Sinusitis chronic and when was it recovered:

Sinusitis chronic in Cardizem

Expand to all the drugs that have ingredients of diltiazem hydrochloride:

Sinusitis chronic and drugs with ingredients of diltiazem hydrochloride

Alternative drugs to, pros and cons of Cardizem:

Cardizem (27,643 reports)

Common Cardizem side effects:

Browse all side effects of Cardizem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sinusitis chronic treatments and more:

Sinusitis chronic (7,909 reports)

COVID vaccines that are related to Sinusitis chronic:

Common drugs associated with Sinusitis chronic:

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride (the active ingredients of Cardizem) and Cardizem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.